Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin/amlodipine/perindopril fixed-dose combination versus atorvastatin/amlodipine in hypertension and dyslipidemia
2014-005378-12Phase 3Completed
- Sponsor
- Servier
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin, amlodipine and perindopril in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Servier. Primary endpoint: Change in office sitting systolic blood pressure. Started Sep 2015; status: completed.
02
Drugs
atorvastatinamlodipineperindopril
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on 2014-005378-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005378-12.